Envestnet Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-59,200
| Closed | -$10.9M | – | 3813 |
|
|
2021
Q2 | $10.9M | Sell |
59,200
-12,973
| -18% | -$2.23M | 0.01% | 1084 |
|
|
2021
Q1 | $11M | Sell |
72,173
-176,377
| -71% | -$27.3M | 0.01% | 987 |
|
|
2020
Q4 | $38.8M | Buy |
248,550
+5,862
| +2% | +$753K | 0.03% | 414 |
|
|
2020
Q3 | $27.8M | Buy |
242,688
+10,770
| +5% | +$1.16M | 0.02% | 453 |
|
|
2020
Q2 | $26M | Buy |
231,918
+24,525
| +12% | +$2.6M | 0.03% | 444 |
|
|
2020
Q1 | $18.6M | Buy |
207,393
+56,435
| +37% | +$5.54M | 0.02% | 469 |
|
|
2019
Q4 | $16.3M | Buy |
150,958
+25,998
| +21% | +$2.78M | 0.02% | 598 |
|
|
2019
Q3 | $12.2M | Sell |
124,960
-268
| -0.2% | -$30.2K | 0.01% | 671 |
|
|
2019
Q2 | $16.4M | Buy |
125,228
+17,335
| +16% | +$2.23M | 0.02% | 547 |
|
|
2019
Q1 | $14.6M | Buy |
107,893
+27,330
| +34% | +$3.4M | 0.02% | 551 |
|
|
2018
Q4 | $7.84M | Buy |
80,563
+78,011
| +3,057% | +$9.22M | 0.01% | 695 |
|
|
2018
Q3 | $355K | Sell |
2,552
-6,539
| -72% | -$820K | ﹤0.01% | 1004 |
|
|
2018
Q2 | $1.13M | Buy |
9,091
+125
| +1% | +$14.6K | ﹤0.01% | 1007 |
|
|
2018
Q1 | $1M | Sell |
8,966
-1,001
| -10% | -$120K | ﹤0.01% | 946 |
|
|
2017
Q4 | $1.19M | Sell |
9,967
-3,620
| -27% | -$441K | ﹤0.01% | 1141 |
|
|
2017
Q3 | $1.91M | Buy |
13,587
+2,313
| +21% | +$314K | ﹤0.01% | 927 |
|
|
2017
Q2 | $1.37M | Sell |
11,274
-2,419
| -18% | -$282K | ﹤0.01% | 1065 |
|
|
2017
Q1 | $1.66M | Sell |
13,693
-662
| -5% | -$85.3K | 0.01% | 1020 |
|
|
2016
Q4 | $1.75M | Sell |
14,355
-5,996
| -29% | -$734K | 0.01% | 984 |
|
|
2016
Q3 | $2.49M | Sell |
20,351
-13,447
| -40% | -$1.73M | 0.01% | 850 |
|
|
2016
Q2 | $3.95M | Buy |
33,798
+5,471
| +19% | +$776K | 0.02% | 724 |
|
|
2016
Q1 | $3.94M | Buy |
28,327
+4,688
| +20% | +$688K | 0.02% | 683 |
|
|
2015
Q4 | $4.51M | Buy |
23,639
+1,889
| +9% | +$330K | 0.02% | 608 |
|
|
2015
Q3 | $3.4M | Buy |
21,750
+472
| +2% | +$86.1K | 0.02% | 721 |
|
|
2015
Q2 | $3.85M | Buy |
21,278
+3,544
| +20% | +$612K | 0.02% | 736 |
|
|
2015
Q1 | $3.07M | Buy |
17,734
+14,086
| +386% | +$2.55M | 0.02% | 776 |
|
|
2014
Q4 | $675K | Sell |
3,648
-2,256
| -38% | -$418K | 0.01% | 630 |
|
|
2014
Q3 | $979K | Buy |
5,904
+818
| +16% | +$134K | 0.01% | 577 |
|
|
2014
Q2 | $795K | Buy |
5,086
+98
| +2% | +$15.5K | 0.01% | 627 |
|
|
2014
Q1 | $759K | Sell |
4,988
-760
| -13% | -$121K | 0.01% | 544 |
|
|
2013
Q4 | $764K | Buy |
5,748
+66
| +1% | +$7.92K | 0.01% | 514 |
|
|
2013
Q3 | $660K | Buy |
5,682
+3,547
| +166% | +$389K | 0.01% | 547 |
|
|
2013
Q2 | $197K | Buy |
+2,135
| New | +$206K | ﹤0.01% | 806 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM